Health Resources and Services Administration and HIV/AIDS Bureau Update Presented to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Laura Cheever, MD ScM Associate Administrator, HIV/AIDS Bureau
HIV/AIDS Bureau Vision and Mission Vision Optimal HIV/AIDS care and treatment for all. Mission Provide leadership and resources to assure access to and retention in high quality, integrated care, and treatment services for vulnerable people living with HIV/AIDS and their families. 2
Moving Forward Framework 3
Challenges in Getting to an AIDS Free Generation Health Disparities Stigma and Discrimination Social Determinants of Health Public Health Infrastructure 4 PUBLIC HEALTH as a KEY DRIVER OF SUCCESS
HIV/AIDS Bureau Priorities National HIV/AIDS Strategy (NHAS) 2020/President s Emergency Plan For AIDS Relief (PEPFAR) 3.0 - Maximize HRSA HAB expertise and resources to operationalize NHAS 2020 and PEPFAR 3.0 Leadership - Enhance and lead national and international HIV care and treatment through evidence-informed innovations, policy development, health workforce development, and program implementation Partnerships - Enhance and develop strategic domestic and international partnerships internally and externally Integration - Integrate HIV prevention, care, and treatment in an evolving healthcare environment Data Utilization - Use data from program reporting systems, surveillance, modeling, and other programs, as well as results from evaluation and special projects efforts to target, prioritize, and improve policies, programs, and service delivery Operations - Strengthen HAB administrative and programmatic processes through Bureau-wide knowledge management, innovation, and collaboration 5
2015 Ryan White HIV/AIDS Program Services Report (RSR) Preview of 2015 Data
2015 Ryan White Services Report (RSR) Overview 533,036 clients received services from RWHAP-funded providers (97% were PLWH) RWHAP served approximately half of estimated persons diagnosed with HIV in the United States Nearly three-quarters (73%) of RWHAP clients are from racial/ethnic minority populations Approximately two-thirds (65%) of RWHAP clients are living at or below the poverty line 7
Ryan White HIV/AIDS Program Clients by Age Group, 2015 United States and 3 Territories 2011 N=554,631 34.0% 2015 N=532,949 31.6% 24.3% 20.0% 20.2% 15.3% 15.0% 16.6% 2.0% 6.4% 3.1% 1.1% 5.1% 5.3% <13 13 24 25 34 35 44 45 54 55 64 65 Age (years) <13 13 24 25 34 35 44 45 54 55 64 65 Age (years) 8
Ryan White HIV/AIDS Program Clients, by Gender, 2015 United States and 3 Territories 1.1% 27.6% 71.3% N=531,816 Male Female Transgender 9
Viral Suppression among RWHAP Clients, 2011 2015 United States and 3 Territories 100 90 80 72.6 75.0 78.6 81.4 83.4 % virally suppressed 70 60 50 40 30 20 10 0 2011 2012 2013 2014 2015 Viral suppression: 1 OAMC visit during the calendar year and 1 viral load reported, with the last viral load result <200 copies/ml. Source: HRSA, HIV/AIDS Bureau, Annual Client-Level Data Report, Ryan White Services Report, 2015 10
Viral Suppression among Key Populations Served by the Ryan White HIV/AIDS Program, 2015 United States and 3 Territories 100 Overall % virally suppressed 90 80 % virally suppressed 70 60 50 40 30 20 10 0 Hispanic men Hispanic women MSM PWID Black/AA women Black/AA men Transgender women Unstably housed Youth YBMSM Young women Viral suppression: 1 OAMC visit during the calendar year and 1 viral load reported, with the last viral load result <200 copies/ml. Source: HRSA, HIV/AIDS Bureau, Annual Client-Level Data Report, Ryan White Services Report, 2015 11
Clients Served by the Ryan White HIV/AIDS Program (non-adap) by Health Care Coverage, 2015 United States and 3 Territories 32.8% N=517,368 20.7% 10.4% 10.4% 8.4% 7.7% 7.2% 2.2% 0.3% 0.0% Medicaid Medicare Multiple coverages Private employer Medicare and Medicaid Private individual Other plan Veterans Administration Indian Health Service No coverage Health care coverage type
Viral Suppression among Clients Served by the Ryan White HIV/AIDS Program (non-adap) by Health Care Coverage, 2015 100 90 80 89.3 88.9 88.3 88.1 87.7 87.5 86.7 83.9 RWHAP overall (83.4%) N=340,085 80.2 77.8 % virally suppressed 70 60 50 40 30 20 10 0 Private individual N=23,834 Private employer N=31,075 Medicare N=34,127 Veterans Administration N=436 Multiple coverages N=36,210 Medicare and Medicaid N=24,471 Other plan N=6,857 Indian Health Service N=149 Medicaid N=106,911 No coverage N=73,120 Health care coverage type Viral suppression: 1 OAMC visit during the calendar year and 1 viral load reported, with the last viral load result <200 copies/ml. Source: HRSA, HIV/AIDS Bureau, Annual Client-Level Data Report, Ryan White Services Report, 2015
Overview Two recent papers illustrate Ryan White HIV/AIDS Program impact using Medical Monitoring Project (MMP) data Service delivery and patient outcomes in Ryan White HIV/AIDS program-funded and non-funded healthcare facilities (Weiser et al., JAMA Internal Medicine, 2015) Ryan White HIV/AIDS program assistance and HIV treatment outcomes (Bradley et al., Clinical Infectious Diseases, 2015) CDC and HRSA collaboration
Weiser (paper #1): Main Findings Service delivery and patient outcomes in Ryan White HIV/AIDS program-funded and non-funded healthcare facilities (Weiser et al., JAMA Internal Medicine, 2015) 2009 and 2011 MMP data show: 34% of facilities received Ryan White HIV/AIDS Program (RWHAP) funding 73% of patients received care at RWHAP-funded facilities
Viral suppression * among low-income patients % (95% CI) Adjusted prevalence ratio (95% CI) RWHAP 73 (70 75) 1.09 (1.02 1.16) Non-RWHAP 67 (62 71) Reference P- value 0.01 *Most recent viral load undetectable or <200 copies /ml Living at or below the federal poverty level
Weiser (paper #1): Primary Conclusion Low income patients were more likely to achieve viral suppression if they received care at a RWHAPfunded facility
Bradley (paper #2): Main Findings Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes (Bradley et al., Clinical Infectious Diseases, 2015) 2009 2012 MMP data show: 41% of patients received RWHAP assistance 25% received RWHAP assistance as a supplement to another healthcare payer type 15% relied solely on RWHAP assistance for HIV care
Adjusted * prevalence of viral suppression by healthcare payer type and RWHAP assistance *Results from logistic regression model adjusted for age, race, place of birth, poverty, education, homelessness, and HIV disease stage
Bradley (paper #2): Primary Conclusion Uninsured and underinsured HIV-infected patients receiving RWHAP assistance were more likely to be prescribed ART and to be virally suppressed than those with other healthcare payer types.
Viral Suppression among RWHAP Clients by State, 2010 to 2015 United States and 3 Territories 2010 2015 AK HI PR VI Viral suppression (%) AK HI PR VI Viral suppression: 1 OAMC visit during the calendar year and 1 viral load reported, with the last viral load result <200 copies/ml. Source: HRSA, HIV/AIDS Bureau, Annual Client-Level Data Report, Ryan White Services Report, 2014 & 2015
Top Ten Increases in Viral Suppression in Ryan White HIV/AIDS Program, by State, 2010 to 2015 United States and 3 Territories State % virally suppressed 2010 % virally suppressed 2015 % point increase Indiana 58.2 86.8 28.6 Louisiana 52.9 76.2 23.3 Mississippi 55.5 78.7 23.2 Ohio 61.1 84.2 23.0 New Jersey 61.6 82.2 20.6 Maryland 63.7 83.7 19.9 Wisconsin 67.9 87.0 19.2 Missouri 66.1 85.0 18.9 District of Columbia 66.8 85.7 18.9 Wyoming 62.8 81.5 18.7 Viral suppression: 1 OAMC visit during the calendar year and 1 viral load reported, with the last viral load result <200 copies/ml. Source: HRSA, HIV/AIDS Bureau, Annual Client-Level Data Report, Ryan White Services Report, 2014 & 2015
Thank you Laura Cheever, MD ScM lcheever@hrsa.gov